|
Real-time Estimate
Tradegate
15:55:53 05/10/2026 +03
|
5-day change | 1st Jan Change | ||
| 15.74 EUR | +1.82% |
|
+1.22% | +47.20% |
| 03:23pm | Harrow Completes Acquisition of Tyrvaya Nasal Spray From Viatris | MT |
| 09-28 | Zymeworks Completes Acquisition of Theravance Biopharma; Updates 2026 Guidance | MT |
| Market Cap | 20.22B 17.96B 16.76B 15.28B 28.82B 1,943B 29.09B 203B 78.61B 993B 75.9B 74.25B 3,188B | P/E 2026 * |
75.7x | P/E 2027 * | 43.3x |
|---|---|---|---|---|---|
| Enterprise Value | 32.17B 28.58B 26.67B 24.31B 45.85B 3,092B 46.28B 323B 125B 1,581B 121B 118B 5,073B | EV / Sales 2026 * |
2.18x | EV / Sales 2027 * | 2.05x |
| Free-Float |
91.44% | Yield 2026 * |
2.89% | Yield 2027 * | 2.97% |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| VTRS | Delayed | |
CBOE
| VTRS | Real-time | |
Börse Stuttgart
| VIA | Delayed | |
Tradegate
| VIA | Real-time | |
Xetra
| VIA | Delayed | |
Boerse Muenchen
| VIA | Real-time | |
Borsa Italiana
| 1VTRS | End-of-day quote | |
Mexican S.E.
| VTRS * | End-of-day quote | |
Deutsche Boerse AG
| VIA | Delayed | |
London S.E.
| 0A5V | Delayed | |
Wiener Boerse
| VTRS | End-of-day quote | |
Swiss Exchange
| VTRS | Delayed | |
Swiss Exchange
| VTRS | Delayed | |
CBOE
| 0A5V | Real-time | |
CBOE
| Real-time |
Last Transcript: Viatris Inc.
| 1 day | +1.81% | ||
| 1 week | +1.22% | ||
| Current month | -2.76% | ||
| 1 month | +5.98% | ||
| 3 months | +7.53% | ||
| 6 months | +32.44% | ||
| Current year | +47.20% |
| 1 week | 15.46 | 16.14 | |
| 1 month | 13.93 | 16.14 | |
| Current year | 10.49 | 16.14 | |
| 1 year | 8.4 | 16.14 | |
| 3 years | 6.26 | 16.14 | |
| 5 years | 6.26 | 16.14 | |
| 10 years | 6.26 | 16.14 |
| Manager | Title | Age | Since |
|---|---|---|---|
Scott Smith
CEO | Chief Executive Officer | 63 | 01/04/2023 |
Paul Campbell
DFI | Director of Finance/CFO | 59 | 08/05/2026 |
Philippe Martin
CTO | Chief Tech/Sci/R&D Officer | - | 15/12/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Wyllie Cornwell
BRD | Director/Board Member | 78 | 16/11/2020 |
James Kilts
BRD | Director/Board Member | 78 | 16/11/2020 |
JoEllen Dillon
BRD | Director/Board Member | 62 | 16/11/2020 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +1.81% | +1.22% | - | - | 20.22B | ||
| -0.61% | -3.43% | +36.07% | +115.04% | 1,019B | ||
| -1.02% | -5.60% | +35.72% | +64.63% | 617B | ||
| +1.11% | -0.58% | +12.36% | +77.95% | 464B | ||
| +0.34% | -3.01% | +61.79% | +41.24% | 356B | ||
| +1.13% | -1.55% | +21.32% | +41.83% | 333B | ||
| +0.99% | -3.13% | +11.15% | +34.82% | 267B | ||
| +0.29% | -4.58% | -6.33% | +9.34% | 244B | ||
| -1.04% | -2.79% | +35.30% | +51.84% | 218B | ||
| -1.87% | -4.10% | +28.44% | +93.66% | 179B | ||
| Average | +0.13% | -3.54% | +26.20% | +58.93% | 410.8B | |
| Weighted average by Cap. | -0.08% | -3.54% | +29.18% | +70.75% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 14.79B 13.14B 12.26B 11.18B 21.08B 1,422B 21.28B 148B 57.51B 727B 55.53B 54.32B 2,333B | 15.04B 13.36B 12.47B 11.37B 21.44B 1,446B 21.64B 151B 58.48B 739B 56.46B 55.23B 2,372B |
| Net income | 142M 126M 117M 107M 202M 13.6B 204M 1.42B 550M 6.95B 531M 520M 22.32B | 298M 265M 247M 226M 425M 28.69B 429M 2.99B 1.16B 14.67B 1.12B 1.1B 47.07B |
| Net Debt | 11.95B 10.62B 9.91B 9.03B 17.04B 1,149B 17.19B 120B 46.47B 587B 44.87B 43.9B 1,885B | 10.68B 9.49B 8.86B 8.08B 15.23B 1,027B 15.37B 107B 41.55B 525B 40.11B 39.24B 1,685B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 02/10/26 | €15.46 | -1.63% | 0 |
| 01/10/26 | €15.71 | -1.15% | 0 |
| 30/09/26 | €15.89 | -0.95% | 0 |
| 29/09/26 | €16.05 | +2.36% | 0 |
| 28/09/26 | €15.68 | +2.66% | 0 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- VTRS Stock
- VTRS Stock
Select your edition
All financial news and data tailored to specific country editions

















